Icade Shares Rise +2.3% Despite a Goldman Sachs Target of €16.30
The real estate company's stock significantly advanced this Wednesday, driven by a broader upward trend on the Paris stock exchange. This rebound occurs even as the stock has still declined nearly 10% over three months, and Goldman Sachs has just lowered its price target.
In today's trading session on April 1st, Icade is trading at €19.81, up 2.32% compared to yesterday's close of €19.36. The stock has gained 3.5% over the past seven days, after reaching a low near its technical support at €18.65, which also corresponds to the lower boundary of the Bollinger Bands. This rebound is part of a favorable dynamic on the Parisian market: the CAC 40 is up 2.12% during the session, while the SBF 120 is up 2.14%. Despite this short-term improvement, the stock remains technically pressured. It is trading well below its 50-day moving average (€20.52) and 200-day moving average (€21.09), indicating a fundamental downward trend. The RSI, at 43, is in a neutral but still fragile zone, far from a strong oversold signal. The most significant resistance is positioned at €21.46, a level that the stock must surpass to reverse the medium-term dynamic.
Goldman Sachs Lowers Price Target
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
On March 30th, Goldman Sachs revised its price target on Icade downward from €17.10 to €16.30, while maintaining its sell recommendation. Based on the current price of €19.81, this target implies a potential downside of about 17.7%, reflecting a fundamentally cautious scenario from the American bank on the real estate company. The next major event for shareholders is scheduled for April 16th with the publication of the first quarter 2026 results. This date will be crucial to assess the operational trajectory of the group, whose stock has still declined 5.67% over the year. From a sectoral perspective, no specific catalysts for the listed real estate market emerged from this session. Today's rebound is more explained by the general movement of the market rather than any company-specific factors.
Confirmation de la guidance annuelle 2026 avec un CFNC Groupe attendu entre 2,90 € et 3,10 € par action
Risks mentioned
Baisse de valeur du patrimoine de -3,1 % à périmètre constant, dont -2,8 % sur les bureaux
Réversion négative attendue sur les renouvellements de baux, potentiel de -7,1 % sur les loyers faciaux
Coût moyen de la dette en hausse à 1,85 %, attendu à environ 2 % fin 2026 ; ICR dégradé à 3,8x
Opportunities identified
Promesse de vente des actifs de santé au Portugal, environ 75 M€ en quote-part Icade
Acquisition des 49 % de la Tour Eqho avec un rendement supérieur à 8 %, relutive sur le CFNC
Réservations résidentielles en hausse de 11,9 % en volume et 6,4 % en valeur
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.